As a result, the insurer is roughly halfway to reaching its goal of decreasing opioid prescriptions by 25 percent by 2019. To date, 158 medical groups representing almost 62,000 physicians have joined Cigna’s initiative to curb opioid prescribing.
Cigna said it analyzes medical and pharmacy claims to identify possible opioid misuse. It also notifies its partner physicians if their opioid prescription patterns don’t align with CDC guidelines.
Beginning July 1, the insurer will also require prior authorization for new long-acting opioid prescriptions not prescribed for cancer, sickle cell disease or hospice care patients. In addition, the majority of new prescriptions for short-acting opioids will face quantity limits.
More articles on opioids:
Opioids fuel 50% spike in drug overdose deaths in NYC
Rutgers releases toolkit to combat opioid epidemic in New Jersey
Louisiana governor backs legislation to limit opioid prescriptions